Clinical trial Recruiting at 1 site Interventional Ages Any age to 5

High-energy liquid diet for young children with chronic cholestasis and severe malnutrition

Official title: Preliminary Study: Effect of Nutrition Therapy on Prealbumin and IGF-1 Level in Severe Malnutrition Under Five Years Old With Chronic Cholestasis

Run by Universitas Indonesia · NCT07569003 · Data updated 2026-11-12

This project will see if a 14-day high-energy liquid diet can raise prealbumin and IGF-1 blood levels in children under 5 with chronic cholestasis and severe malnutrition.

More Progressive Familial Intrahepatic Cholestasis trials

Quick facts

Study typeInterventional
AgesAny age to 5 Years
SexAll
Enrollment15 (estimated)
SponsorUniversitas Indonesia
Academic / other
Locations1 site (Jakarta Pusat, DKI Jakarta)
StatusRecruiting
StartedApril 6, 2026
Main results expectedJune 2026
Study endsJuly 2026
Registry record updatedMay 6, 2026
Trial IDNCT07569003 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3 to 59 months with diagnosed chronic cholestasis and severe malnutrition whose guardians consent and who can use a nasogastric tube if indicated.

Probably not a fit

Children with heart failure, chronic kidney disease, HIV, recent severe acute infections, post-transplant status, or those who are exclusively breastfed are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls malnourished children aged 3 to 59 months with chronic cholestasis to receive a prescribed high-energy liquid diet for 14 days. Blood samples for prealbumin and IGF-1 are taken at baseline and on day 15 to measure biochemical response. Daily food diaries, stool and vomiting records, and monitoring for allergic reactions are collected throughout the intervention, while anthropometric measurements are recorded on days 0, 8, and 15. The protocol excludes children with major comorbidities, recent severe infections, post-transplant status, or exclusive breastfeeding.

Why it matters

Potential benefit: If successful, the diet could improve short-term nutrition markers and help support growth in malnourished children with chronic cholestasis.

How similar studies have gone: Prior nutritional interventions in cholestatic pediatric populations have shown improvements in weight and some biochemical markers, but short-term effects on prealbumin and IGF-1 from a 14-day high-energy liquid diet are not well-established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children under 5 years old
* Diagnosed with chronic cholestasis and severe malnutrition
* Parental/guardian informed consent
* Willingness to use a nasogastric tube (NGT) if indicated
* Covered by national health insurance or other insurance

Exclusion Criteria:

* Comorbidities (heart failure, chronic kidney disease, HIV)
* Severe acute infections (acute gastroenteritis, dengue fever, pneumonia)
* Post-liver transplant
* Post-Kasai portoenterostomy (jaundice-free)
* Currently exclusively breastfeeding
* Use of steroids or NSAIDs within two weeks prior to the study.
* Receiving a transfusion of whole blood, fresh frozen plasma, or platelets within one week prior to the study

Where it's running

  • Faculty of Medicine, University of Indonesia, Jakarta, DKI Jakarta 10430
    Jakarta Pusat, DKI Jakarta, Indonesia
    Recruiting

Study contacts

  • Principal investigator: Tri Faranita, dr, Sp.A — Department of Child Health, Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital
  • Study coordinator: Tri Faranita, dr, Sp.A
  • Email: tri.faranita@ui.ac.id
  • Phone: +628126016641

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.